Stock Report

Download full stock data and analysis for free Last Updated: 28-Aug-2026

Stock Rating

See the stock’s health at a glance, before it's too late.

Wealth Insight New Issue

This month’s issue could change how you invest, read now.

Recently Viewed

Clear All

BridgeBio Pharma (BBIO) Peer Comparison

Stock Card factsheet share-fund-plan-icon

$78.68

up-down-arrow $-0.69 (-0.87%)

As on 27-Aug-2026 16:00EDT

Market cap

info icon

$15,933 Mln

Revenue (TTM)

info icon

$692 Mln

P/E Ratio

info icon

--

P/B Ratio

info icon

123.7

Div. Yield

info icon

0 %

Edit peer-selector-edit
BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM) Dr. Reddy's Laboratories - ADR
Market cap ($ Mln)
 15,933 13,215 11,972 10,883 10,088
Revenue ($ Mln)
 692 831 5,020 777 332,834
Net Profit ($ Mln)
 -696.24 54.90 -199.00 -191.64 33,166.55
Net Margin (%)
 -100.64 6.61 -3.96 -24.68 9.96
RoE (%)
 -- 8.11 -3.03 -223.36 8.88
Price to Earnings
 -- 271.67 -- -- 28.83
Price-To-Book
 123.68 18.72 1.79 130.86 2.52

Income Statement ($ Mln)

BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM) Dr. Reddy's Laboratories - ADR
Operating Revenue arrow
691.84 830.81 5,020.00 776.57 332,834.17
Cost of Revenue arrow
47.45 14.09 2,380.00 52.53 165,910.29
Gross Profit arrow
473.81 748.43 2,050.00 591.02 190,428.00
Operating Expenses arrow
1,187.86 810.32 2,178.00 912.58 131,728.10
Operating Profit (EBIT) arrow
-543.47 6.41 462.00 -188.54 35,195.77
Other Income arrow
0.00 0.00 0.00 0.00 0.00
Profit before Tax arrow
-706.17 26.37 -166.00 -191.09 41,359.76
Provision for Tax arrow
-7.73 -35.26 33.00 0.56 8,582.66
Profit after Tax (Net Income) arrow
-696.24 54.90 -199.00 -191.64 33,166.55
Minority Interest arrow
6.48 0.00 0.00 0.00 389.00
Consolidated Profit arrow
0.00 0.00 0.00 0.00 25,570.00

Liabilities ($ Mln)

BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM) Dr. Reddy's Laboratories - ADR
Shareholder's Funds arrow
-2,515.22 705.78 6,588.00 83.30 383,428.00
Minority Interest arrow
6.48 0.00 0.00 0.00 389.00
Non-Current Liabilities arrow
2,832.54 29.12 5,121.00 217.70 31,229.00
Current Liabilities arrow
890.65 153.80 1,852.00 460.45 157,341.00
Total Liabilities arrow
936.03 836.65 13,358.00 689.81 492,989.00

Assets ($ Mln)

BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM) Dr. Reddy's Laboratories - ADR
Non-Current Assets arrow
124.16 449.03 9,764.00 104.88 275,974.00
Current Assets arrow
1,093.14 439.68 3,797.00 656.57 299,331.00
Total Assets arrow
936.03 836.65 13,358.00 689.81 492,989.00
Total Debt* arrow
2,493.78 9.42 3,918.00 219.21 71,952.00
Net Current Assets arrow
0.00 285.87 1,945.00 0.00 141,990.00

Cashflow ($ Mln)

BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM) Dr. Reddy's Laboratories - ADR
Cash From Operating Activities arrow
-445.91 142.00 560.00 -93.41 46,428.00
Cash Flow from Investing Activities arrow
-24.49 69.76 -279.00 -0.48 -58,077.00
Cash from Financing Activities arrow
359.29 -220.37 -275.00 101.47 18,911.00
Net Cash Inflow / Outflow arrow
-- -- -- -- --

Ratios

Profitability Ratios

 BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM) Dr. Reddy's Laboratories - ADR
ROCE (%) arrow
-159.44 14.87 -2.21 -63.21 16.61
ROE (%) arrow
41.15 8.11 -3.03 -223.36 8.88
ROA (%) arrow
-39.04 5.52 -1.30 -15.97 4.76
EBIT Margin (%) arrow
-89.09 3.17 1.61 -17.57 11.08
Net Margin (%) arrow
-100.64 6.61 -3.96 -24.68 9.96
Cash Profit Margin (%) arrow
0.00 0.00 0.00 0.00 0.00

Growth Ratios

 BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM) Dr. Reddy's Laboratories - ADR
Revenue Growth (%) arrow
193.38 16.02 11.95 56.87 -0.43
EBIT Growth (%) arrow
5.05 -79.11 -90.61 42.45 -53.96
Net Profit Growth (%) arrow
10.33 -58.66 -145.85 22.38 -41.61
EPS Growth (%) arrow
12.58 -62.44 -146.42 25.75 -41.56
Book Value Growth (%) arrow
-36.90 12.98 -3.87 9.44 9.58

Valuation Ratios

 BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM) Dr. Reddy's Laboratories - ADR
Price / Earnings arrow
-20.69 41.86 -48.47 -50.48 0.19
Price / Book Value arrow
-7.27 6.44 1.72 104.73 0.03
Dividend Yield (%) arrow
-- -- -- -- --
EV/EBITDA arrow
-25.60 55.67 21.77 -54.53 0.00
Market Cap ($ Cr) arrow
-- -- -- -- --

Solvency Ratios

 BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM) Dr. Reddy's Laboratories - ADR
Debt to Equity arrow
0.00 0.00 0.58 0.00 0.00
Short term debt to equity ratio arrow
-0.22 0.00 0.01 0.85 0.16
Current Ratio arrow
1.23 2.86 2.05 1.43 1.90
Quick Ratio arrow
1.17 2.77 1.10 1.34 1.39
Interest Coverage arrow
-6.86 -- 0.36 -37.09 10.86

Operating Efficiency Ratios

 BridgeBio Pharma (BBIO) Corcept Therapeutics (CORT) Elanco Animal Health (ELAN) Axsome Therapeutics (AXSM) Dr. Reddy's Laboratories - ADR
Debtors to sales (%) arrow
36.78 9.26 22.95 35.73 37.38
Asset Turnover arrow
0.39 0.84 0.33 0.65 0.48
Receivable days arrow
52.44 28.27 70.73 104.82 115.08
Inventory Days arrow
172.81 355.76 226.89 167.98 181.99
Payable days arrow
296.14 785.55 45.50 529.03 56.23
Cash Conversion Cycle arrow
-70.89 -401.52 252.12 -256.23 240.84
*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.
loading...
loading...